Literature DB >> 24589872

Long-term exposure to air pollution and cardiovascular mortality: an analysis of 22 European cohorts.

Rob Beelen1, Massimo Stafoggia, Ole Raaschou-Nielsen, Zorana Jovanovic Andersen, Wei W Xun, Klea Katsouyanni, Konstantina Dimakopoulou, Bert Brunekreef, Gudrun Weinmayr, Barbara Hoffmann, Kathrin Wolf, Evangelia Samoli, Danny Houthuijs, Mark Nieuwenhuijsen, Anna Oudin, Bertil Forsberg, David Olsson, Veikko Salomaa, Timo Lanki, Tarja Yli-Tuomi, Bente Oftedal, Geir Aamodt, Per Nafstad, Ulf De Faire, Nancy L Pedersen, Claes-Göran Östenson, Laura Fratiglioni, Johanna Penell, Michal Korek, Andrei Pyko, Kirsten Thorup Eriksen, Anne Tjønneland, Thomas Becker, Marloes Eeftens, Michiel Bots, Kees Meliefste, Meng Wang, Bas Bueno-de-Mesquita, Dorothea Sugiri, Ursula Krämer, Joachim Heinrich, Kees de Hoogh, Timothy Key, Annette Peters, Josef Cyrys, Hans Concin, Gabriele Nagel, Alex Ineichen, Emmanuel Schaffner, Nicole Probst-Hensch, Julia Dratva, Regina Ducret-Stich, Alice Vilier, Françoise Clavel-Chapelon, Morgane Stempfelet, Sara Grioni, Vittorio Krogh, Ming-Yi Tsai, Alessandro Marcon, Fulvio Ricceri, Carlotta Sacerdote, Claudia Galassi, Enrica Migliore, Andrea Ranzi, Giulia Cesaroni, Chiara Badaloni, Francesco Forastiere, Ibon Tamayo, Pilar Amiano, Miren Dorronsoro, Michail Katsoulis, Antonia Trichopoulou, Paolo Vineis, Gerard Hoek.   

Abstract

BACKGROUND: Air pollution has been associated with cardiovascular mortality, but it remains unclear as to whether specific pollutants are related to specific cardiovascular causes of death. Within the multicenter European Study of Cohorts for Air Pollution Effects (ESCAPE), we investigated the associations of long-term exposure to several air pollutants with all cardiovascular disease (CVD) mortality, as well as with specific cardiovascular causes of death.
METHODS: Data from 22 European cohort studies were used. Using a standardized protocol, study area-specific air pollution exposure at the residential address was characterized as annual average concentrations of the following: nitrogen oxides (NO2 and NOx); particles with diameters of less than 2.5 μm (PM2.5), less than 10 μm (PM10), and 10 μm to 2.5 μm (PMcoarse); PM2.5 absorbance estimated by land-use regression models; and traffic indicators. We applied cohort-specific Cox proportional hazards models using a standardized protocol. Random-effects meta-analysis was used to obtain pooled effect estimates.
RESULTS: The total study population consisted of 367,383 participants, with 9994 deaths from CVD (including 4,992 from ischemic heart disease, 2264 from myocardial infarction, and 2484 from cerebrovascular disease). All hazard ratios were approximately 1.0, except for particle mass and cerebrovascular disease mortality; for PM2.5, the hazard ratio was 1.21 (95% confidence interval = 0.87-1.69) per 5 μg/m and for PM10, 1.22 (0.91-1.63) per 10 μg/m.
CONCLUSION: In a joint analysis of data from 22 European cohorts, most hazard ratios for the association of air pollutants with mortality from overall CVD and with specific CVDs were approximately 1.0, with the exception of particulate mass and cerebrovascular disease mortality for which there was suggestive evidence for an association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24589872     DOI: 10.1097/EDE.0000000000000076

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  67 in total

Review 1.  Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence.

Authors:  Yixing Du; Xiaohan Xu; Ming Chu; Yan Guo; Junhong Wang
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 2.  Ambient air pollution and lung disease in China: health effects, study design approaches and future research.

Authors:  Jeffrey H Mandel; Christine Wendt; Charles Lo; Guangbiao Zhou; Marshall Hertz; Gurumurthy Ramachandran
Journal:  Front Med       Date:  2015-06-18       Impact factor: 4.592

Review 3.  Air Pollution Stress and the Aging Phenotype: The Telomere Connection.

Authors:  Dries S Martens; Tim S Nawrot
Journal:  Curr Environ Health Rep       Date:  2016-09

4.  A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework.

Authors:  George D Thurston; Howard Kipen; Isabella Annesi-Maesano; John Balmes; Robert D Brook; Kevin Cromar; Sara De Matteis; Francesco Forastiere; Bertil Forsberg; Mark W Frampton; Jonathan Grigg; Dick Heederik; Frank J Kelly; Nino Kuenzli; Robert Laumbach; Annette Peters; Sanjay T Rajagopalan; David Rich; Beate Ritz; Jonathan M Samet; Thomas Sandstrom; Torben Sigsgaard; Jordi Sunyer; Bert Brunekreef
Journal:  Eur Respir J       Date:  2017-01-11       Impact factor: 16.671

Review 5.  Air Pollution and Skin Aging.

Authors:  Tamara Schikowski; Anke Hüls
Journal:  Curr Environ Health Rep       Date:  2020-03

6.  PM2.5 air pollution and cause-specific cardiovascular disease mortality.

Authors:  Richard B Hayes; Chris Lim; Yilong Zhang; Kevin Cromar; Yongzhao Shao; Harmony R Reynolds; Debra T Silverman; Rena R Jones; Yikyung Park; Michael Jerrett; Jiyoung Ahn; George D Thurston
Journal:  Int J Epidemiol       Date:  2020-02-01       Impact factor: 7.196

7.  Insulin sensitizers prevent fine particulate matter-induced vascular insulin resistance and changes in endothelial progenitor cell homeostasis.

Authors:  Petra Haberzettl; James P McCracken; Aruni Bhatnagar; Daniel J Conklin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-03-25       Impact factor: 4.733

Review 8.  Impact of Particulate Air Pollution on Cardiovascular Health.

Authors:  Zhen An; Yuefei Jin; Juan Li; Wen Li; Weidong Wu
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

9.  Air Pollution and Cardiovascular Disease: A Focus on Vulnerable Populations Worldwide.

Authors:  Martin Tibuakuu; Erin D Michos; Ana Navas-Acien; Miranda R Jones
Journal:  Curr Epidemiol Rep       Date:  2018-09-19

Review 10.  Air Pollution and Cardiometabolic Disease: An Update and Call for Clinical Trials.

Authors:  Robert D Brook; David E Newby; Sanjay Rajagopalan
Journal:  Am J Hypertens       Date:  2017-12-08       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.